Eli Lilly hasnt announced what it will cost
First, assess your expectations and timeline
It works by inhibiting the DPP-4 enzyme, which normally breaks down incretin hormones such as GLP-1 (Glucagon-Like Peptide-1) and GIP (Gastric Inhibitory Polypeptide) which help to increased insulin secretion to stimulate the pancreas to release more insulin in response to meals, particularly when blood sugar levels are elevated and decreased glucagon secretion is a hormone that signals the liver to produce glucose
Canada: The Canadian patent (CA 2,675,150) expires December 2028, with no patent term extension granted
Sergey Terushkin, MD, FACS, is a board-certified surgeon and weight loss specialist at Florida Surgery & Weight Loss Center in Hollywood, FL
Extraglycaemic Effects on Lipids Monami et al